{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:43:59Z","timestamp":1793169839995,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.otc.2021.05.020","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T04:42:07Z","timestamp":1626756127000},"page":"1057-1068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Allergy, Immunotherapy, and Alternative Treatments for Dizziness"],"prefix":"10.1016","volume":"54","author":[{"given":"M. Jennifer","family":"Derebery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.otc.2021.05.020_bib1","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1001\/jama.1923.02650260021006","article-title":"Meni\u00e8re's syndrome caused by allergy","volume":"81","author":"Duke","year":"1923","journal-title":"JAMA"},{"key":"10.1016\/j.otc.2021.05.020_bib2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Espenshade","year":"2008","journal-title":"Br J Pharma"},{"key":"10.1016\/j.otc.2021.05.020_bib3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00405-015-3731-5","article-title":"Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres disease","volume":"273","author":"M\u00f8ller","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib4","first-page":"297","article-title":"Innate immune defense in the inner ear: mucines are expressed by the human endolymphatic sac","volume":"230","author":"M\u00f8ller","year":"2017","journal-title":"J\u00a0Anat"},{"key":"10.1016\/j.otc.2021.05.020_bib5","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1002\/lary.25242","article-title":"Gene expression demonstrates an immunological capacity of the human endolymphatic sac","volume":"125","author":"M\u00f8ller","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2021.05.020_bib6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/00005537-200309000-00038","article-title":"Cell proliferation in the endolymphatic sac in\u00a0situ after the rat Waldeyer ring equivalent immunostimulation","volume":"113","author":"Yan","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2021.05.020_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0030-6665(02)00019-1","article-title":"Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease","volume":"35","author":"Paparella","year":"2002","journal-title":"Otolaryngol Clin N Am"},{"key":"10.1016\/j.otc.2021.05.020_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ncl.2005.01.012","article-title":"Pharmacologic treatment of persons with dizziness","volume":"23","author":"Hain","year":"2005","journal-title":"Neurol Clin"},{"key":"10.1016\/j.otc.2021.05.020_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOO.0b013e32830ce796","article-title":"Issues, indications, and controversies regarding intratympanic steroid perfusion","volume":"16","author":"Hamid","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.020_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.otc.2010.05.004","article-title":"Allergy and its relation to Meni\u00e8re's disease","volume":"43","author":"Derebery","year":"2010","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.otc.2021.05.020_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00405-006-0147-2","article-title":"Non-specific immunological determinations in Meni\u00e8re's disease: any role in clinical practice?","volume":"264","author":"Savastano","year":"2007","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/MAO.0b013e3182565a27","article-title":"Type 1 allergy-induced endolymphatic hydrops and the suppressive effect of leukotriene receptor antagonist","volume":"33","author":"Takeda","year":"2012","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otc.2021.05.020_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1067\/mhn.2000.105715","article-title":"Prevalence of allergy in M\u00e8ni\u00e9re\u2019s disease","volume":"123","author":"Derebery","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.020_bib14","unstructured":"Derebery MJ, Berliner KI. Allergic management in M\u00e8ni\u00e9re\u2019s disease: a prospective study. Presented at the American Academy of Otolaryngic Allergy Annual Meeting. Orlando (FL); September 19, 2003."},{"key":"10.1016\/j.otc.2021.05.020_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.otc.2011.03.004","article-title":"Allergic and immunologic features of M\u00e9ni\u00e8re's disease","volume":"44","author":"Derebery","year":"2011","journal-title":"Otolaryngol Clin N Am"},{"key":"10.1016\/j.otc.2021.05.020_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF02849975","article-title":"Provocation of endolymphatic hydrops with a prick test in Meniere\u2019s disease","volume":"24","author":"Topuz","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.otc.2021.05.020_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0194-5998(99)70186-5","article-title":"Electrocochleographic changes after intranasal allergen challenge: a possible diagnostic tool in patients with Meniere\u2019s disease","volume":"121","author":"Gibbs","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.020_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000276124","article-title":"Human endolymphatic sac: evidence for a role in inner ear immune defense","volume":"52","author":"Altermatt","year":"1990","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.otc.2021.05.020_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/00016480600606723","article-title":"Immune-mediated inner ear disease","volume":"126","author":"Bovo","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib20","first-page":"5072582","article-title":"Update on vertigo in autoimmune disorders, from diagnosis to treatment","volume":"2018","author":"Girasoli","year":"2018","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.otc.2021.05.020_bib21","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/lary.24163","volume":"123","author":"Ghossaini","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2021.05.020_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/000164801300006236","article-title":"Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases","volume":"121","author":"Boulassel","year":"2001","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib23","first-page":"1","article-title":"Sudden hearing disorders occurring simultaneously or successively on both sides (German)","volume":"37","author":"Lehnhardt","year":"1958","journal-title":"Z\u00a0Laryngol Rhinol Otol"},{"key":"10.1016\/j.otc.2021.05.020_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/000348947908800501","article-title":"Autoimmune sensorineural hearing loss","volume":"88","author":"McCabe","year":"1979","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib25","first-page":"396","author":"Harris","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.020_bib26","first-page":"146","article-title":"Methotrexate management of immune-mediated cochleovestibular disorders","volume":"116","author":"Sismanis","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.020_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1529-0131(200104)45:2<146::AID-ANR167>3.0.CO;2-I","article-title":"Open trial of methotrexate as treatment for autoimmune hearing loss","volume":"45","author":"Matteson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.otc.2021.05.020_bib28","first-page":"1037","article-title":"Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients","volume":"28","author":"Salley","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.otc.2021.05.020_bib29","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.290.14.1875","article-title":"Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial","volume":"290","author":"Harris","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.otc.2021.05.020_bib30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00405-006-0096-9","article-title":"Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: a physiopathologic approach","volume":"263","author":"Garc\u00eda-Berrocal","year":"2006","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1288\/00005537-198911000-00006","article-title":"Theoretical and practical implications for plasmapheresis in autoimmune inner ear disease","volume":"99","author":"Luetje","year":"1989","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2021.05.020_bib32","first-page":"572","article-title":"Plasmapheresis in autoimmune inner ear disease: long-term follow-up","volume":"18","author":"Luetje","year":"1997","journal-title":"Am J Otol"},{"key":"10.1016\/j.otc.2021.05.020_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000095897","article-title":"Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss","volume":"11","author":"Van Wijk","year":"2006","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.otc.2021.05.020_bib34","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/MAO.0000000000000566","article-title":"An open label study to evaluate the safety and efficacy of intratympanic golimumab therapy in patients with autoimmune inner ear disease","volume":"35","author":"Derebery","year":"2014","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otc.2021.05.020_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000320606","article-title":"A\u00a0pilot study of rituximab in immune-mediated inner ear disease","volume":"16","author":"Cohen","year":"2011","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.otc.2021.05.020_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000351289","article-title":"Autoimmune inner ear disease: a retrospective review of forty-seven patients","volume":"18","author":"Matsuoka","year":"2013","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.otc.2021.05.020_bib37","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4049\/jimmunol.1002275","article-title":"IL-1\u03b2 is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease","volume":"186","author":"Pathak","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.otc.2021.05.020_bib38","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1172\/JCI76503","article-title":"Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease","volume":"124","author":"Vambutas","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.otc.2021.05.020_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000189783","article-title":"M\u00e9ni\u00e8re's disease is a viral neuropathy","volume":"71","author":"Gacek","year":"2009","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.otc.2021.05.020_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amjoto.2014.03.016","article-title":"Recovery of hearing in Meniere's disease after antiviral treatment","volume":"36","author":"Gacek","year":"2015","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.otohns.2004.08.012","article-title":"Randomized double-blinded, placebo-controlled trial of famciclovir for reduction of Meniere\u2019s disease symptoms","volume":"131","author":"Derebery","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.020_bib42","first-page":"1","article-title":"Is there any evidence for complementary and alternative therapy in Menieres disease","volume":"4","author":"Sen","year":"2004","journal-title":"Internet J Otorhinolaryngol"},{"key":"10.1016\/j.otc.2021.05.020_bib43","unstructured":"Available at: https:\/\/www.dizziness-and-balance.com\/disorders\/menieres\/treatment\/men_alt.html"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:54:00Z","timestamp":1758466440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666521001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0030666521001213"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2021.05.020","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergy, Immunotherapy, and Alternative Treatments for Dizziness","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2021.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}